Posted by Defense World Staff on Feb 14th, 2026
Athira Pharma (NASDAQ:LONA – Get Free Report) was upgraded by investment analysts at Wall Street Zen to a “hold” rating in a report issued on Saturday.
Separately, Weiss Ratings initiated coverage on shares of Athira...
More of this article »